Quick Takeaways
- Paul A. Friedman has 3 issuer positions tracked on this page.
- Estimated disclosed ownership value: $484,919,577.
- Recent insider filing activity is available below.
- Info
- Significant Ownership
- Insider Ownership
Insider Trading & Ownership of Paul A. Friedman
- Location
- Wilmington, DE
- Summary
- The estimated net worth of Paul A. Friedman is at least $484,919,577 dollars as of 13 Jan 2026. Paul A. Friedman is the Director of MADRIGAL PHARMACEUTICALS, INC. and owns shares of MADRIGAL PHARMACEUTICALS, INC. (MDGL) stock worth about $484.92M.
- Signature
- /s/ Mardi Dier, as Attorney-in-Fact
- All Insider Reports
- All Insider Reports
Follow Filing Activity
Follow Paul A. Friedman and return when a new Insider Trading filing appears.
This tracks SEC filing changes for this page using existing product update flows.
What Changed
- Largest disclosed position: MADRIGAL PHARMACEUTICALS, INC. ($484,919,577).
- Past-year value change for that position: -$101,802,886.
Why This Matters
- This page translates Forms 3/4/5 into a quick ownership context before you inspect each transaction row.
- You can cross-check role, issuer, and filing chronology directly against the SEC source.
Official SEC Source
Filed on Form 4
Insider ownership context is sourced from SEC Forms 3, 4, and 5.
See Original FilingOwnership of Paul A. Friedman
| Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
|---|---|---|---|---|---|---|
| MDGL | MADRIGAL PHARMACEUTICALS, INC. | Director | $484,919,577 | -$101,802,886 | -17% | 09 Jan 2026 |
| ALXN | ALEXION PHARMACEUTICALS, INC. | Director | 21 Jul 2021 | |||
| PRLD | Prelude Therapeutics Inc | Director | 12 Jun 2025 |
Insider Transactions Reported by Paul A. Friedman:
| Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
|---|
* An asterisk sign (*) next to the price indicates that the price is likely invalid.